677 related articles for article (PubMed ID: 25585947)
21. Chemokine MCP1/CCL2 and RANTES/CCL5 gene polymorphisms influence Henoch-Schönlein purpura susceptibility and severity.
Yu HH; Liu PH; Yang YH; Lee JH; Wang LC; Chen WJ; Chiang BL
J Formos Med Assoc; 2015 Apr; 114(4):347-52. PubMed ID: 25839768
[TBL] [Abstract][Full Text] [Related]
22. Association between endothelial nitric oxide synthase Glu298Asp gene polymorphism and diabetic nephropathy susceptibility.
Zhou TB; Xu HL; Yin SS
Ren Fail; 2013; 35(1):173-8. PubMed ID: 23113598
[TBL] [Abstract][Full Text] [Related]
23. Increased CD8+ T cells in patients with Henoch-Schonlein purpura nephritis exhibit suppressive immune activity.
Fengyong Z; Zhixiang F; Jiajia P; Qin L; Min Q; Guoliang W; Ziyan Z
Immunol Lett; 2022 Oct; 250():23-28. PubMed ID: 36174770
[TBL] [Abstract][Full Text] [Related]
24. Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis.
Yoshioka T; Xu YX; Yoshida H; Shiraga H; Muraki T; Ito K
Arch Dis Child; 1998 Nov; 79(5):394-9. PubMed ID: 10193250
[TBL] [Abstract][Full Text] [Related]
25. Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism with the risk of end-stage renal disease.
Zhou TB; Yin SS
Ren Fail; 2013; 35(4):573-8. PubMed ID: 23464568
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis.
Amoli MM; Thomson W; Hajeer AH; Calviño MC; Garcia-Porrua C; Ollier WE; Gonzalez-Gay MA
J Rheumatol; 2002 Nov; 29(11):2367-70. PubMed ID: 12415593
[TBL] [Abstract][Full Text] [Related]
27. Henoch-Schönlein purpura nephritis: initial risk factors and outcomes in a Latin American tertiary center.
Buscatti IM; Casella BB; Aikawa NE; Watanabe A; Farhat SCL; Campos LMA; Silva CA
Clin Rheumatol; 2018 May; 37(5):1319-1324. PubMed ID: 29330742
[TBL] [Abstract][Full Text] [Related]
28. Lack of association between macrophage migration inhibitory factor gene promoter (-173 G/C) polymorphism and childhood Henoch-Schönlein purpura in Turkish patients.
Nalbantoglu S; Tabel Y; Mir S; Berdeli A
Cytokine; 2013 Apr; 62(1):160-4. PubMed ID: 23523092
[TBL] [Abstract][Full Text] [Related]
29. Renin-angiotensin system gene polymorphisms: association with susceptibility to Henoch-Schonlein purpura and renal involvement.
Ozkaya O; Söylemezoğlu O; Gönen S; Misirlioğlu M; Tuncer S; Kalman S; Buyan N; Hasanoğlu E
Clin Rheumatol; 2006 Nov; 25(6):861-5. PubMed ID: 16521052
[TBL] [Abstract][Full Text] [Related]
30. Polymorphism of the ACE gene in Henoch-Schönlein purpura nephritis.
Dudley J; Afifi E; Gardner A; Tizard EJ; McGraw ME
Pediatr Nephrol; 2000 Mar; 14(3):218-20. PubMed ID: 10752761
[TBL] [Abstract][Full Text] [Related]
31. The relationship between red cell distribution width and the risk of Henoch-Schönlein purpura nephritis.
Zhu X; Zhang M; Lan F; Wei H; He Q; Li S; Qin X
Br J Biomed Sci; 2018 Jan; 75(1):30-35. PubMed ID: 28990845
[TBL] [Abstract][Full Text] [Related]
32. Chemokine MCP1/CCL2 gene polymorphism influences Henoch-Schönlein purpura susceptibility in Iranian Azeri-Turkish patients.
Bonyadi M; Mohammadian T; Rafeey M; Sadeghi Shabestri M; Mortazavi F; Aliyari B
Int J Dermatol; 2015 Nov; 54(11):1269-74. PubMed ID: 26234573
[TBL] [Abstract][Full Text] [Related]
33. The G894t, T-786c and 4b/a polymorphisms in Enos gene and cancer risk: a meta-analysis.
Zhang L; Chen LM; Wang MN; Chen XJ; Li N; Huang YD; Chen M
J Evid Based Med; 2014 Dec; 7(4):263-9. PubMed ID: 25586457
[TBL] [Abstract][Full Text] [Related]
34. [Expression and significance of endothelial microparticles in children with Henoch-Schönlein purpura].
Fu SQ; Guo YJ; Song CL
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Oct; 20(10):831-834. PubMed ID: 30369358
[TBL] [Abstract][Full Text] [Related]
35. Effect of paraoxonase 1 gene polymorphisms on clinical course of Henoch-Schönlein purpura.
Yilmaz A; Emre S; Agachan B; Bilge I; Yilmaz H; Ergen A; Isbir T; Sirin A
J Nephrol; 2009; 22(6):726-32. PubMed ID: 19967651
[TBL] [Abstract][Full Text] [Related]
36. Association of Interleukin-2 Gene Polymorphism with Henoch-schönlein Purpura Nephritis.
Cao J; Zhang J; Xu H; Li W; Shi J; Ye Q
Iran J Allergy Asthma Immunol; 2023 Jun; 22(3):319-326. PubMed ID: 37524668
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of alpha-smooth muscle actin and c-Met as biomarkers of the degree of severity of Henoch-Schonlein purpura nephritis.
Zhang L; Han C; Sun C; Meng H; Ye F; Na S; Chen F; Zhang D; Jin X
Transl Res; 2013 Jan; 161(1):26-36. PubMed ID: 23041443
[TBL] [Abstract][Full Text] [Related]
38. Exploring potential predictors of Henoch-Schönlein purpura nephritis: a pilot investigation on urinary metabolites.
Yu M; Song X; Guo J; Feng Q; Tian J
Eur J Pediatr; 2024 Apr; ():. PubMed ID: 38668796
[TBL] [Abstract][Full Text] [Related]
39. Beneficial effects of creatine phosphate sodium for the treatment of Henoch-Schönlein purpura in patients with early renal damage detected using urinary kidney injury molecule-1 levels.
Zhang J; Zeng H; Wang N; Tian X; Dou W; Shi P
Eur J Pediatr; 2016 Jan; 175(1):49-55. PubMed ID: 26220440
[TBL] [Abstract][Full Text] [Related]
40. Proteome analysis reveals novel serum biomarkers for Henoch-Schönlein purpura in Chinese children.
Liu L; Liu H; Zhu K; Zhang L; Yin X; Han L; Wang M; Gao S; Xiao X; Yang J; Huang C; Huang Y
J Proteomics; 2023 Mar; 276():104841. PubMed ID: 36796721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
